← Browse by Condition
Medical Condition
extensive stage small cell lung cancer
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 4, Phase 1, Phase 2
NCT05588388 Phase 2
Recruiting
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Enrollment
39 pts
Location
United States
Sponsor
Kamya Sankar
NCT05874401 Phase 4
Recruiting
Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Enrollment
302 pts
Location
Spain
Sponsor
Pharmacosmos A/S
NCT06536868 Phase 2
Recruiting
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Enrollment
40 pts
Location
China
Sponsor
Second Hospital of Shanxi Medi...
NCT06362252 Phase 1, Phase 2
Recruiting
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Enrollment
123 pts
Location
United States, Franc...
Sponsor
Daiichi Sankyo